{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T19:07:22Z","timestamp":1785265642705,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T00:00:00Z","timestamp":1507593600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00105-017-4061-x","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T07:54:53Z","timestamp":1507622093000},"page":"867-875","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Okulokutaner und okul\u00e4rer Albinismus","Oculocutaneous and ocular albinism"],"prefix":"10.1007","volume":"68","author":[{"given":"A. S.","family":"Kubasch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Meurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,10]]},"reference":[{"issue":"3","key":"4061_CR1","first-page":"723","volume":"37","author":"JF Gamella","year":"2013","unstructured":"Gamella JF, Carrasco-Munoz EM, Nunez Negrillo AM (2013) Oculocutaneous albinism and consanguineous marriage among Spanish Gitanos or Cale \u2013 a study of 83 cases. Coll Antropol 37(3):723\u2013734","journal-title":"Coll Antropol"},{"issue":"3","key":"4061_CR2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1468-3083.2003.00767.x","volume":"17","author":"JF Okulicz","year":"2003","unstructured":"Okulicz JF, Shah RS, Schwartz RA, Janniger CK (2003) Oculocutaneous albinism. J\u00a0Eur Acad Dermatol Venereol 17(3):251\u2013256","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"4061_CR3","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00439-003-0998-1","volume":"113","author":"RA King","year":"2003","unstructured":"King RA, Pietsch J, Fryer JP, Savage S, Brott MJ, Russell-Eggitt I et al (2003) Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype. Hum Genet 113(6):502\u2013513","journal-title":"Hum Genet"},{"issue":"3","key":"4061_CR4","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1086\/377569","volume":"73","author":"RA King","year":"2003","unstructured":"King RA, Willaert RK, Schmidt RM, Pietsch J, Savage S, Brott MJ et\u00a0al (2003) MC1R mutations modify the classic phenotype of oculocutaneous albinism type 2 (OCA2). Am J Hum Genet 73(3):638\u2013645","journal-title":"Am J Hum Genet"},{"issue":"1","key":"4061_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdermsci.2007.12.008","volume":"51","author":"T Suzuki","year":"2008","unstructured":"Suzuki T, Tomita Y (2008) Recent advances in genetic analyses of oculocutaneous albinism types 2 and 4. J\u00a0Dermatol Sci 51(1):1\u20139","journal-title":"J Dermatol Sci"},{"issue":"4429","key":"4061_CR6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(01)78113-5","volume":"172","author":"AE Garrod","year":"1908","unstructured":"Garrod AE (1908) The Croonian Lectures on inborn errors of metabolism. Lancet 172(4429):142\u2013148","journal-title":"Lancet"},{"issue":"5","key":"4061_CR7","doi-asserted-by":"publisher","first-page":"a017046","DOI":"10.1101\/cshperspect.a017046","volume":"4","author":"Y Yamaguchi","year":"2014","unstructured":"Yamaguchi Y, Hearing VJ (2014) Melanocytes and their diseases. Cold Spring Harb Perspect Med 4(5):a17046. \n                        https:\/\/doi.org\/10.1101\/cshperspect.a017046","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"6","key":"4061_CR8","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1021\/acscentsci.6b00230","volume":"3","author":"Y Huang","year":"2017","unstructured":"Huang Y, Li Y, Hu Z, Yue X, Proetto MT, Jones Y et\u00a0al (2017) Mimicking melanosomes: molydopamine nanoparticles as artificial microparasols. ACS Cent Sci 3(6):564\u2013569","journal-title":"ACS Cent Sci"},{"key":"4061_CR9","first-page":"905","volume-title":"Dermatology: 2\u2011volume set","author":"J Bolognia","year":"2012","unstructured":"Bolognia J (2012) Melanocyte biology. In: Bolognia Schaffer JJJJ (Hrsg) Dermatology: 2\u2011volume set. Elsevier Saunders, Amsterdam, S 905\u2013911"},{"key":"4061_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/905472","author":"B Kamaraj","year":"2014","unstructured":"Kamaraj B, Purohit R (2014) Mutational analysis of oculocutaneous albinism: a\u00a0compact review. Biomed Res Int. \n                        https:\/\/doi.org\/10.1155\/2014\/905472","journal-title":"Biomed Res Int"},{"issue":"8","key":"4061_CR11","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s00347-007-1571-4","volume":"104","author":"B K\u00e4smann-Kellner","year":"2007","unstructured":"K\u00e4smann-Kellner B, Seitz B (2007) Ph\u00e4notyp des visuellen Systems bei okulokutanem und okul\u00e4rem Albinismus. Ophthalmologe 104(8):648\u2013661","journal-title":"Ophthalmologe"},{"issue":"4","key":"4061_CR12","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/MOP.0000000000000514","volume":"29","author":"AL Fogel","year":"2017","unstructured":"Fogel AL, Sarin KY, Teng JMC (2017) Genetic diseases associated with an increased risk of skin cancer development in childhood. Curr Opin Pediatr 29(4):426\u2013433","journal-title":"Curr Opin Pediatr"},{"issue":"8","key":"4061_CR13","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s00347-007-1572-3","volume":"104","author":"B Schmitz","year":"2007","unstructured":"Schmitz B, Krick C, Kasmann-Kellner B (2007) Morphology of the optic chiasm in albinism. Ophthalmologe 104(8):662\u2013665","journal-title":"Ophthalmologe"},{"issue":"11","key":"4061_CR14","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/S0161-6420(85)33832-0","volume":"92","author":"RA King","year":"1985","unstructured":"King RA, Lewis RA, Townsend D, Zelickson A, Olds DP, Brumbaugh J (1985) Brown oculocutaneous albinism. Clinical, ophthalmological, and biochemical characterization. Ophthalmology 92(11):1496\u20131505","journal-title":"Ophthalmology"},{"issue":"1","key":"4061_CR15","doi-asserted-by":"crossref","first-page":"e84494","DOI":"10.1371\/journal.pone.0084494","volume":"9","author":"MB Dolinska","year":"2014","unstructured":"Dolinska MB, Kovaleva E, Backlund P, Wingfield PT, Brooks BP, Sergeev YV (2014) Albinism-causing mutations in recombinant human tyrosinase alter intrinsic enzymatic activity. PLOS ONE 9(1):e84494","journal-title":"PLOS ONE"},{"issue":"3","key":"4061_CR16","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.exer.2005.08.013","volume":"82","author":"L Ni-Komatsu","year":"2006","unstructured":"Ni-Komatsu L, Orlow SJ (2006) Heterologous expression of tyrosinase recapitulates the misprocessing and mistrafficking in oculocutaneous albinism type 2: effects of altering intracellular pH and pink-eyed dilution gene expression. Exp Eye Res 82(3):519\u2013528","journal-title":"Exp Eye Res"},{"issue":"11","key":"4061_CR17","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/exd.12549","volume":"23","author":"VK Morya","year":"2014","unstructured":"Morya VK, Dung NH, Singh BK, Lee HB, Kim EK (2014) Homology modelling and virtual screening of P\u2011protein in a\u00a0quest for novel antimelanogenic agent and in vitro assessments. Exp Dermatol 23(11):838\u2013842","journal-title":"Exp Dermatol"},{"issue":"1","key":"4061_CR18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jdermsci.2014.11.006","volume":"77","author":"T Kondo","year":"2015","unstructured":"Kondo T, Namiki T, Coelho SG, Valencia JC, Hearing VJ (2015) Oculocutaneous albinism: developing novel antibodies targeting the proteins associated with OCA2 and OCA4. J\u00a0Dermatol Sci 77(1):21\u201327","journal-title":"J Dermatol Sci"},{"key":"4061_CR19","first-page":"213","volume-title":"The Pigmentary System","author":"WS Oetting","year":"1998","unstructured":"Oetting WS (1998) The Pigmentary System. In: Nordlund Vincent Hearing King Ortonne JJREBJRJ-P (Hrsg) The Pigmentary System. Oxford University Press, Oxford, S 213\u2013249"},{"issue":"Pt 2","key":"4061_CR20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1042\/bj3550259","volume":"355","author":"K Toyofuku","year":"2001","unstructured":"Toyofuku K, Wada I, Spritz RA, Hearing VJ (2001) The molecular basis of oculocutaneous albinism type 1 (OCA1): sorting failure and degradation of mutant tyrosinases results in a\u00a0lack of pigmentation. Biochem\u00a0J 355(Pt 2):259\u2013269","journal-title":"Biochem J"},{"issue":"12","key":"4061_CR21","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1096\/fj.01-0216com","volume":"15","author":"K Toyofuku","year":"2001","unstructured":"Toyofuku K, Wada I, Valencia JC, Kushimoto T, Ferrans VJ, Hearing VJ (2001) Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild-type proteins. FASEB\u00a0J 15(12):2149\u20132161","journal-title":"FASEB J"},{"issue":"2","key":"4061_CR22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/humu.10311","volume":"23","author":"U Rundshagen","year":"2004","unstructured":"Rundshagen U, Zuhlke C, Opitz S, Schwinger E, Kasmann-Kellner B (2004) Mutations in the MATP gene in five German patients affected by oculocutaneous albinism type 4. Hum Mutat 23(2):106\u2013110","journal-title":"Hum Mutat"},{"issue":"1","key":"4061_CR23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/pcmr.12167","volume":"27","author":"L Montoliu","year":"2014","unstructured":"Montoliu L, Gronskov K, Wei AH, Martinez-Garcia M, Fernandez A, Arveiler B et al (2014) Increasing the complexity: new genes and new types of albinism. Pigment Cell Melanoma Res 27(1):11\u201318","journal-title":"Pigment Cell Melanoma Res"},{"issue":"3","key":"4061_CR24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1055\/s-0042-101556","volume":"232","author":"MN Preising","year":"2016","unstructured":"Preising MN, Lorenz B (2016) Albinism and the range of fundus hypopigmentation, macular hypoplasia, and nystagmus. Klin Monbl Augenheilkd 232(3):243\u2013250","journal-title":"Klin Monbl Augenheilkd"},{"issue":"9","key":"4061_CR25","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1371\/journal.pbio.0060236","volume":"6","author":"VM Lopez","year":"2008","unstructured":"Lopez VM, Decatur CL, Stamer WD, Lynch RM, McKay BS (2008) L\u2011DOPA is an endogenous ligand for OA1. Plos Biol 6(9):e236","journal-title":"Plos Biol"},{"issue":"10","key":"4061_CR26","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1172\/JCI59372","volume":"121","author":"IF Onojafe","year":"2011","unstructured":"Onojafe IF, Adams DR, Simeonov DR, Zhang J, Chan CC, Bernardini IM et\u00a0al (2011) Nitisinone improves eye and skin pigmentation defects in a\u00a0mouse model of oculocutaneous albinism. J\u00a0Clin Invest 121(10):3914\u20133923","journal-title":"J Clin Invest"},{"issue":"10","key":"4061_CR27","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1172\/JCI59763","volume":"121","author":"P Manga","year":"2011","unstructured":"Manga P, Orlow SJ (2011) Informed reasoning: repositioning of nitisinone to treat oculocutaneous albinism. J\u00a0Clin Invest 121(10):3828\u20133831","journal-title":"J Clin Invest"},{"key":"4061_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15687","author":"S Ribero","year":"2017","unstructured":"Ribero S, Carrera C, Tell-Marti G, Pastorino C, Badenas C, Garcia A et al (2017) Amelanotic melanoma in oculocutaneous albinism: a\u00a0genetic, dermoscopic and reflectance confocal microscopy study. Br J Dermatol. \n                        https:\/\/doi.org\/10.1111\/bjd.15687","journal-title":"Br J Dermatol"},{"key":"4061_CR29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1471-2407-14-157","volume":"14","author":"SK Kiprono","year":"2014","unstructured":"Kiprono SK, Chaula BM, Beltraminelli H (2014) Histological review of skin cancers in African Albinos: a\u00a010-year retrospective review. BMC Cancer 14:157","journal-title":"BMC Cancer"},{"issue":"2","key":"4061_CR30","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/03014460500075423","volume":"32","author":"PM Lund","year":"2005","unstructured":"Lund PM (2005) Oculocutaneous albinism in southern Africa: population structure, health and genetic care. Ann Hum Biol 32(2):168\u2013173","journal-title":"Ann Hum Biol"},{"issue":"5","key":"4061_CR31","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2133.1975.tb03116.x","volume":"92","author":"AN Okoro","year":"1975","unstructured":"Okoro AN (1975) Albinism in Nigeria. A clinical and social study. Br J Dermatol 92(5):485\u2013492","journal-title":"Br J Dermatol"},{"issue":"4","key":"4061_CR32","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1590\/abd1806-4841.20153498","volume":"90","author":"M Maia","year":"2015","unstructured":"Maia M, Volpini BM, dos Santos GA, Rujula MJ (2015) Quality of life in patients with oculocutaneous albinism. An Bras Dermatol 90(4):513\u2013517","journal-title":"An Bras Dermatol"},{"key":"4061_CR33","volume-title":"Albino man","author":"S Wojtkowiak","year":"2006","unstructured":"Wojtkowiak S (2006) Albino man. \n                        https:\/\/www.flickr.com\/photos\/82075546@N00\/330824072\/\n                        \n                    . Zugegriffen: 13.09.2017"},{"key":"4061_CR34","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/1750-1172-8-168","volume":"8","author":"L Dotta","year":"2013","unstructured":"Dotta L, Parolini S, Prandini A, Tabellini G, Antolini M, Kingsmore SF et al (2013) Clinical, laboratory and molecular signs of immunodeficiency in patients with partial oculo-cutaneous albinism. Orphanet J Rare Dis 8:168","journal-title":"Orphanet J Rare Dis"},{"key":"4061_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/cge.12631","author":"J Song","year":"2015","unstructured":"Song J, Feng Y, Acke FR, Coucke P, Vleminckx K, Dhooge IJ (2015) Hearing loss in Waardenburg syndrome: a\u00a0systematic review. Clin Genet. \n                        https:\/\/doi.org\/10.1111\/cge.12631","journal-title":"Clin Genet"},{"issue":"12","key":"4061_CR36","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00105-015-3717-7","volume":"66","author":"M B\u00f6hm","year":"2015","unstructured":"B\u00f6hm M (2015) Differenzialdiagnostik der Hypomelanosen. Hautarzt 66(12):945\u2013960","journal-title":"Hautarzt"},{"issue":"11","key":"4061_CR37","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/qjmed\/hcv101","volume":"108","author":"A Bassi","year":"2015","unstructured":"Bassi A, Berti S, Galeone M (2015) Piebaldism. QJM 108(11):915","journal-title":"QJM"},{"key":"4061_CR38","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.genom.9.081307.164303","volume":"9","author":"M Huizing","year":"2008","unstructured":"Huizing M, Helip-Wooley A, Westbroek W, Gunay-Aygun M, Gahl WA (2008) Disorders of lysosome-related organelle biogenesis: clinical and molecular genetics. Annu Rev Genomics Hum Genet 9:359\u2013386","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"2","key":"4061_CR39","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/pcmr.12051","volume":"26","author":"AH Wei","year":"2013","unstructured":"Wei AH, Li W (2013) Hermansky-Pudlak syndrome: pigmentary and non-pigmentary defects and their pathogenesis. Pigment Cell Melanoma Res 26(2):176\u2013192","journal-title":"Pigment Cell Melanoma Res"},{"issue":"1","key":"4061_CR40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/MOH.0b013e3282f2bcce","volume":"15","author":"J Kaplan","year":"2008","unstructured":"Kaplan J, De Domenico I, Ward DM (2008) Chediak-Higashi syndrome. Curr Opin Hematol 15(1):22\u201329","journal-title":"Curr Opin Hematol"},{"issue":"6","key":"4061_CR41","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.1111\/pde.12663","volume":"32","author":"A Nouriel","year":"2015","unstructured":"Nouriel A, Zisquit J, Helfand AM, Anikster Y, Greenberger S (2015) Griscelli syndrome type 3: two new cases and review of the literature. Pediatr Dermatol 32(6):e245\u2013e248","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"4061_CR42","doi-asserted-by":"crossref","first-page":"869","DOI":"10.4103\/neuroindia.NI_762_16","volume":"65","author":"C Sahu","year":"2017","unstructured":"Sahu C, Netam SS, Bhutada BR, Jaiswal SJ (2017) Griscelli syndrome: a rare disorder. Neurol India 65(4):869\u2013870","journal-title":"Neurol India"},{"issue":"4","key":"4061_CR43","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0002-9343(78)90858-6","volume":"65","author":"C Griscelli","year":"1978","unstructured":"Griscelli C, Durandy A, Guy-Grand D, Daguillard F, Herzog C, Prunieras M (1978) A syndrome associating partial albinism and immunodeficiency. Am J Med 65(4):691\u2013702","journal-title":"Am J Med"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-017-4061-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-017-4061-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-017-4061-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T08:35:11Z","timestamp":1509352511000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-017-4061-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,10]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["4061"],"URL":"https:\/\/doi.org\/10.1007\/s00105-017-4061-x","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,10]]}}}